Compare Boston Scientific Corporation (BSX) vs Cincinnati Financial Corporation (CINF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Boston Scientific Corporation vs Cincinnati Financial Corporation — how do they compare? Boston Scientific Corporation trades at $51.72 (market cap $74.19B), while Cincinnati Financial Corporation trades at $172.45 (market cap $26.58B). The key difference: Boston Scientific Corporation is far larger — about 2.8× Cincinnati Financial Corporation's market cap, and Cincinnati Financial Corporation pays a 2.17% dividend while Boston Scientific Corporation pays none. Which is the better fit depends on your goals.
| BSX | CINF | |
|---|---|---|
Market Cap | $74.19B | $26.58B |
Sector | Health | Financials |
52-Week High | $108.14 | $192.03 |
52-Week Low | $42.63 | $149.79 |
Enterprise Value | $86.27B | $25.71B |
Dividend Yield | — | 2.17% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Boston Scientific (BSX) trades at $51.66, up 2.38% today, showing strong momentum with three consecutive quarterly earnings beats. The stock maintains bullish technical signals with moving averages supporting upward movement, though oscillators indicate potential overbought conditions. Fundamentally, BSX demonstrates robust growth with 2025 revenue reaching $20.07B and net income margin expanding to 14.43%, supported by strong cash flow generation of $1.54B in 2025.
The outlook remains positive with 86% analyst buy ratings and a $67.21 consensus price target offering 30% upside potential. Key risks include competitive pressures in WATCHMAN and electrophysiology segments, along with recent guidance cuts. Insider buying by the CEO and director signals management confidence in the company's long-term prospects despite near-term challenges.
Cincinnati Financial (CINF) trades at $172.87, down 0.57% on the day, with a bearish technical signal despite strong fundamentals. The company reported Q2 2026 earnings miss ($1.43 vs. $1.84 expected) but maintains robust revenue growth and profitability with a 23.84% net income margin. Cash flow trends show improvement, with 2025 net cash flow reaching $448 million. Analyst consensus remains positive with a $195 price target, though technical indicators suggest near-term pressure.
CINF presents a value opportunity with attractive valuation metrics (P/E 8.18, P/B 1.59) and consistent dividend growth. Key risks include catastrophe losses impacting underwriting results and commercial lines performance. The stock's current technical weakness may offer entry points for long-term investors seeking quality insurance exposure with strong ROE of 21.48%.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →About Cincinnati Financial Corporation
Cincinnati Financial Corp is a property and casualty insurance company that generates income through written premiums. A select group of independent agencies actively markets the company's business, home, and automotive insurance within their communities. These agents offer the company's personal lines as well as its standard market, excess, and surplus commercial line policies in many regions in the United States. Cincinnati Financial also offers leasing and financing services. The vast majority of the company's revenue is generated through commercial lines, followed by personal lines.
Read more on CINF →
